BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.17.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260819T170000
DTEND;TZID=Australia/Sydney:20260819T170000
DTSTAMP:20260505T060732Z
CREATED:20260505T060732Z
LAST-MODIFIED:20260505T060732Z
UID:10000293-1787158800-1787158800@melanoma.org.au
SUMMARY:MRFF Genomics Health Futures
DESCRIPTION:The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that: \nStream 1 (TCR): develop genomic tools and technologies to identify genetic predisposition to cancer and improve screening and targeted intervention. Focus on increased access to genomic testing and on liquid biopsy. \nStream 2 (TCR): conduct scalable research to enhance novel gene discoveries\, increase diagnostic rates and enable disease modelling to support development of targeted therapies or prevention strategies. \nStream 3 (Incubator): develop novel methods for using polygenic risk scores to identify subgroups of the population at high risk of common and complex diseases (cardiovascular disease\, diabetes and other common and/or complex diseases). \nStream 4 (Incubator): develop novel methods for improving accuracy and usefulness of polygenic risk scores to stratify people with common cancers for surveillance and treatment (breast cancer\, colorectal cancer\, prostate cancer and other common cancers) \nStream 5 (TCR): undertake research to enhance or streamline uptake of clinical genomics into practice. \nStream 6 (Accelerator): develop and maintain infrastructure to support research collaboration by enabling data sharing\, portability\, longevity and connectivity of analysis across Australia. Research conducted should address emerging ethical\, legal and social issues associated with the governance of clinical and genomic datasets with particular focus on the application of advanced analytics (e.g. AI) to enhance the diagnostic utility of genomics. \nApplicants must propose research that addresses these objectives and those of the Genomics Health Futures Mission as outlined in the Roadmap and Implementation Plan. \nKey Dates \n\nMinimum data due date: 22 July 2026\nApplications close: 19 August 2026\nIndicative funding status: Funding anticipated to be awarded from June 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-genomics-health-futures/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF-Genomics-Health-Futures600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260722T170000
DTEND;TZID=Australia/Sydney:20260722T170000
DTSTAMP:20260505T060230Z
CREATED:20260505T060230Z
LAST-MODIFIED:20260505T060230Z
UID:10000292-1784739600-1784739600@melanoma.org.au
SUMMARY:MRFF BioMedTech Incubator
DESCRIPTION:The MRFF 2026 BioMedTech Incubator Program provides grants of financial assistance to support medical research and medical innovation projects through the establishment of BioMedTech Incubators. \nThis grant is for an eligible organisation who can establish a working incubator\, to partner with Australian small and medium enterprises (SMEs) to progress new and innovative medical research projects through the early stages of development. \nThe 2026 BioMedTech Grant Opportunity is part of the Medical Research Future Fund under the Medical Research Commercialisation Initiative. \nThis opportunity looks to fund suitable organisations to identify\, select and support Australian SMEs undertaking early-stage medical research and medical innovation projects that have commercial potential. \nThe intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by increasing the number of SMEs developing novel biomarkers\, diagnostics\, therapeutics\, assistive devices and/or digital technologies that have progressed through the early stages of research and development to the point where they are ‘de-risked’ and attractive to private investment for commercialisation. \nApplicants may propose to support development of innovations in their area/s of strength (i.e. applicants are not required to propose a program that covers the breadth of the biomedtech sector). \nGrants of up to $33 million to establish BioMedTech Incubators. \n\nKey Dates\nApplications close: 22 July 2026\nIndicative funding status: Funding anticipated to be awarded from December 2026 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-incubator/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/05/MRFF_Incubator-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260609T170000
DTEND;TZID=Australia/Sydney:20260609T170000
DTSTAMP:20260602T043120Z
CREATED:20260602T043120Z
LAST-MODIFIED:20260602T043120Z
UID:10000304-1781024400-1781024400@melanoma.org.au
SUMMARY:NSW Health Medical Devices Fund
DESCRIPTION:The Medical Devices Fund provides grants to drive the commercialisation of highly innovative new devices and technologies in NSW\, addressing gaps in the product life cycle between early-stage research and mature investment opportunities. \n\nThe Medical Devices Fund aims to: \n\n\n\nSupport individuals\, companies\, public and private hospitals\, medical research institutes\, universities\, other public sector research organisations\, and the medical devices industry\, to take local innovation to market\n\n\n\n\nIncrease the uptake of NSW medical devices that are cost effective and contribute to improved patient outcomes.\n\nFor Round 14\, applicants with projects that address the following NSW Health Research and Innovation Strategy aligned priorities are encouraged to apply: \n\nWomen’s Health\nFemale Entrepreneurs\nAboriginal Health\n\nApplicants with projects that do not address the above priorities are also able to apply. \n\nThe program funds project activities used for any purpose that meets the objectives of the program\, subject to the exclusions below. \nExamples of activities that can be funded include: \n\n\n\ndevice development\, including proof-of-concept\, prototyping\, and piloting studies\n\n\n\n\nmanufacturing samples for product trials\n\n\n\n\nclinical assessment\n\n\n\n\nlocating other national and international trials and research relevant to the product under development\n\n\n\n\nbusiness planning\, including conducting market and product assessments\n\n\n\n\nintellectual property management\n\n\n\n\ncommercialisation\n\n\n\n\ncapital raising\n\n\n\n\nKey Dates:\nPreliminary applications close: 9 June 2026\, 5:00pm AEST\nFull applications for this grant are by invitation only.\nNotification of final outcomes: February 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nswhealth-medical-devices-fund/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/NSW-Medical-Devices-Fund-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260430T170000
DTEND;TZID=Australia/Sydney:20260430T170000
DTSTAMP:20260303T011942Z
CREATED:20260303T011942Z
LAST-MODIFIED:20260303T011942Z
UID:10000266-1777568400-1777568400@melanoma.org.au
SUMMARY:NSW Translational Research Grants Scheme
DESCRIPTION:Funding research projects that translate into better patient outcomes\, health service delivery\, and population health and wellbeing \nThe Translational Research Grants Scheme aims to: \n\nfoster the generation of high-quality research that is directly relevant to clinical\, health service and population health practice in NSW\nenhance health and medical research capability and capacity within the NSW health system\nsupport projects that have the potential to be translated into policy and practice\, including research that can be generalised and scaled in other LHDs/SHNs across the state\nreduce the time from evidence generation to practice implementation.\n\nHost organisations must identify and engage relevant partners to support effective delivery of the research project and implementation of the outcomes in NSW. \nRound 10 NOW OPEN. \nKey Dates\nEOI due to Host Organisation: 30 April 2026\nFull application due to Host Organisation: 31 July 2026\nFull applications due to NSW Ministry of Health\, Office for Health and Medical Research: 28 August 2026\nSuccessful applicants notified: Late February 2027\nResearch begins: 1 July 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nsw-translational-research-grants/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NSW-Health-Translational-Research-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20260318T170000
DTEND;TZID=Australia/Sydney:20260318T170000
DTSTAMP:20260203T031044Z
CREATED:20260203T031044Z
LAST-MODIFIED:20260203T031044Z
UID:10000243-1773853200-1773853200@melanoma.org.au
SUMMARY:ARC Linkage Projects
DESCRIPTION:The Linkage Program promotes national and international research partnerships between researchers and business\, industry\, community organisations and other publicly funded research agencies. By supporting the development of partnerships\, the ARC encourages the transfer of skills\, knowledge and ideas as a basis for securing commercial and other benefits of research. \nThe Linkage Projects grant opportunity supports projects which initiate or develop long term strategic research alliances to apply advanced knowledge to problems\, acquire new knowledge and as a basis for securing commercial and other benefits of research. \nThere will be one assessment round for Linkage Projects 2026. \nThe Linkage Projects scheme objectives are to: \n\nsupport internationally competitive research projects and teams on challenges or opportunities of relevance to research end-users;\nfoster the establishment and strengthening of research alliances between higher education organisations and research end-users;\nenhance the scale and focus of research\, including in Australian Government priority areas.\n\nApplications for funding under the Linkage Projects scheme must include at least one Partner Organisation. The Partner Organisation must make a contribution in cash and/or in kind to the project. The combined Partner Organisation contributions for an application (i.e. the total of the cash and in-kind contributions of the Partner Organisations) must at least match the total funding requested from the ARC. \nThe Linkage Projects scheme provides project funding of $50\,000 to $300\,000 per year for two to five years. \nThis scheme is intended to support researchers from higher education organisations and industry to build partnerships with organisations\, to conduct research which will benefit the organisations and Australia. \nKey Dates \nApplications close: 18 March 2026 \nAnnouncement: 10 December 2026 to 9 March 2027 \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/arc-linkage-projects/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/01/ARC-Linkage-Projects-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20251205T170000
DTEND;TZID=Australia/Sydney:20251205T170000
DTSTAMP:20251203T015911Z
CREATED:20251118T004913Z
LAST-MODIFIED:20251203T015911Z
UID:10000211-1764954000-1764954000@melanoma.org.au
SUMMARY:Perpetual Impact Grant
DESCRIPTION:The Perpetual IMPACT Philanthropy Application program creates meaningful connections between philanthropists and Not-for-Profit (NFP) organisations. It provides a platform for NFP’s to showcase how they deliver improved outcomes for the communities they serve. \nThe grant supports high-quality\, sustainable impact by identifying organisations that demonstrate strong governance\, capable leadership\, strategic clarity\, and a clear focus on measurable outcomes. \nKey Dates\nApplications open: Monday 27 October 2025\, 9.00am AEDT\nApplications close: Friday 5 December 2025\, 5.00pm AEDT \nSEE GRANT GUIDELINES PDFSEE WEBSITE
URL:https://melanoma.org.au/event/perpetual-impact-grant/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/png:https://melanoma.org.au/wp-content/uploads/2025/11/Perpetual-1.png
END:VEVENT
END:VCALENDAR